Surgical treatment of hepatocellular carcinoma after Fontan operation: three case reports and review of the literature

被引:4
|
作者
Shiraishi, Jin [1 ]
Itoh, Shinji [1 ]
Tomino, Takahiro [1 ]
Yoshiya, Shohei [1 ]
Nagao, Yoshihiro [1 ]
Kayashima, Hiroto [1 ]
Harada, Noboru [1 ]
Sakamoto, Ichiro [2 ]
Tsutsui, Hiroyuki [2 ]
Yoshizumi, Tomoharu [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka, Japan
关键词
Fontan-associated liver disease; Hepatocellular carcinoma; Hepatectomy; Recurrence; MANAGEMENT; PATIENT;
D O I
10.1007/s12328-023-01795-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We herein describe three patients with Fontan-associated liver disease who developed hepatocellular carcinoma (HCC). The first patient was a 28-year-old woman who had undergone the Fontan operation (FO) at the age of 4 years. She was diagnosed with HCC (cT4aN0M0, Stage IVA, UICC 8th edition), for which she underwent extended posterior right sectionectomy and partial hepatectomy of S2. She developed recurrence of peritoneal dissemination after 12 months, and she was alive 18 months after surgery. The second patient was a 43-year-old man who had undergone the FO at the age of 3 years. He was diagnosed with HCC (cT2N0M0, Stage II), for which he underwent laparoscopic-assisted partial hepatectomy of S3. He remained free from recurrent HCC for 17 months. The third patient was a 21-year-old woman who had undergone the FO at the age of 3 years. She was diagnosed with HCC (cT3N0M0, Stage III), for which she underwent laparoscopic-assisted partial hepatectomy of S2 and S4. She remained free from recurrent HCC for 30 months. We reviewed 18 surgical cases of HCC arising from Fontan-associated liver disease, including our 3 cases, and found that a high preoperative alpha-fetoprotein concentration might be a predictor of HCC recurrence.
引用
收藏
页码:559 / 566
页数:8
相关论文
共 50 条
  • [21] Rupture of hepatocellular carcinoma during pregnancy: 3 case reports and review of the literature
    丁光辉
    杨家和
    程树群
    李楠
    刘凯
    戴炳华
    沈丽
    张艳玲
    乔琳
    吴孟超
    Journal of Medical Colleges of PLA, 2005, (05) : 316 - 320
  • [22] Small cell carcinoma of the prostate: Three case reports and a literature review
    Huang, I-Shen
    Huang, William J. S.
    Lin, Alex T. L.
    Chen, Kuang-Kuo
    UROLOGICAL SCIENCE, 2013, 24 (04) : 131 - 135
  • [23] Surgical Resection for Hepatocellular Carcinoma with Cardiac Cirrhosis after the Fontan Procedure
    Takuma, Yoshitaka
    Fukada, Yuji
    Iwadou, Shota
    Miyatake, Hirokazu
    Uematsu, Shuji
    Okamoto, Ryoichi
    Sato, Daisuke
    Matsukawa, Hiroyoshi
    Shiozaki, Shigehiro
    Kamada, Masahiro
    Morito, Toshiaki
    Araki, Yasuyuki
    INTERNAL MEDICINE, 2016, 55 (22) : 3265 - 3272
  • [24] Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib Three case reports
    Tomonari, Tetsu
    Sato, Yasushi
    Tanaka, Hironori
    Tanaka, Takahiro
    Taniguchi, Tatsuya
    Sogabe, Masahiro
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Muguruma, Naoki
    Saito, Yu
    Imura, Satoru
    Bando, Yoshimi
    Shimada, Mitsuo
    Takayama, Tetsuji
    MEDICINE, 2020, 99 (42) : E22782
  • [25] Second malignant tumors after treatment of nasopharyngeal carcinoma: Four case reports and literature review
    Malone, JP
    Levin, RJ
    SKULL BASE-AN INTERDISCIPLINARY APPROACH, 2002, 12 (02): : 87 - 91
  • [26] Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation
    Nii, Masaki
    Inuzuka, Ryo
    Inai, Kei
    Shimada, Eriko
    Shinohara, Tokuko
    Kogiso, Tomomi
    Ono, Hiroshi
    Ootsuki, Shinichi
    Kurita, Yoshihiko
    Takeda, Atsuhito
    Hirono, Keiichi
    Takei, Kota
    Yasukochi, Satoshi
    Yoshikawa, Tadahiro
    Furutani, Yoshiyuki
    Shinozaki, Tomohiro
    Matsuyama, Yutaka
    Senzaki, Hideaki
    Tokushige, Katsutoshi
    Nakanishi, Toshio
    CIRCULATION, 2021, 144 (25) : 2043 - 2045
  • [27] Commentary: Hepatocellular carcinoma after the Fontan operation: Are we paying attention? Comment
    Burkhart, Harold M.
    Phillips, Sabrina D.
    JTCVS TECHNIQUES, 2020, 2 : 133 - 134
  • [28] Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
    Yoon, Jun Sik
    Lee, Dong Ho
    Cho, Eun Ju
    Song, Mi Kyoung
    Choi, Young Hun
    Kim, Gi Beom
    Lee, Yun Bin
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Haeryoung
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Bae, Eun Jung
    CANCERS, 2020, 12 (07) : 1 - 12
  • [29] A Meta-Analysis of Cumulative Incidence of Hepatocellular Carcinoma After the Fontan Operation
    Hansen, Sophie
    Gilroy, Richard
    Lindsay, Ian
    Doty, John R.
    Butschek, Ross A.
    Danford, Christopher J.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (12) : 4467 - 4475
  • [30] A META-ANALYSIS OF CUMULATIVE INCIDENCE OF HEPATOCELLULAR CARCINOMA AFTER THE FONTAN OPERATION
    Hansen, Sophie
    Gilroy, Richard
    Lindsay, Ian
    Doty, John
    Butschek, Ross
    Danford, Christopher
    HEPATOLOGY, 2023, 78 : S1798 - S1799